⌘K

Eterna Therapeutics Inc. (ERNA)

$1.51 0.67% $0.01 Healthcare

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.

Market cap

$8.17M

CEO

Dr. Matthew Angel Ph.D.

Full time employees

10.00

Headquarters

San Diego, CA

IPO Date

Aug 29, 1991

Price-to-earnings (PE) Ratio

-0.34

Earnings-per-share (EPS)

$-4.43

Cash ratio (TTM)

0.66

Current ratio (TTM)

0.79

Net profit margin (TTM)

-19,912.17%

PE ratio (TTM)

-0.47

PEG ratio (TTM)

-0.00

Price-to-book ratio (TTM)

-3.17

Price-to-sales ratio (TTM)

94.02

Quick ratio (TTM)

0.70

Return on assets (TTM)

-46.11%

Return on equity (TTM)

-1,465.77%

Similar stocks (19)

Apellis Pharmaceuticals, Inc.

APLS

$36.31 -3.48% $-1.31

Downtrend

Structure Therapeutics Inc.

GPCR

$40.00 -2.06% $-0.84

Downtrend

Arcus Biosciences, Inc.

RCUS

$16.91 -5.79% $-1.04

Neutral

Relay Therapeutics, Inc.

RLAY

$8.11 6.71% $0.51

Downtrend

Day One Biopharmaceuticals, Inc.

DAWN

$13.63 -3.54% $-0.50

Downtrend

Cullinan Oncology, Inc.

CGEM

$16.93 -5.68% $-1.02

Uptrend

Annexon, Inc.

ANNX

$7.16 -0.62% $-0.04

Uptrend

iTeos Therapeutics, Inc.

ITOS

$12.10 -27.54% $-4.60

Uptrend

Inozyme Pharma, Inc.

INZY

$5.99 -0.17% $-0.01

Uptrend

TScan Therapeutics, Inc.

TCRX

$5.74 0.00% $0.00

Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.54 -2.31% $-0.06

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.66 -6.69% $-0.05

Downtrend

Immix Biopharma, Inc.

IMMX

$1.85 -1.07% $-0.02

Downtrend

Unicycive Therapeutics, Inc.

UNCY

$0.38 -5.01% $-0.02

Downtrend

Palisade Bio, Inc.

PALI

$3.89 2.64% $0.10

Downtrend

TransCode Therapeutics, Inc.

RNAZ

$0.26 0.50% $0.00

Downtrend

Phio Pharmaceuticals Corp.

PHIO

$3.31 0.30% $0.01

Downtrend

ZyVersa Therapeutics, Inc.

ZVSA

$2.38 9.17% $0.20

Downtrend

Revelation Biosciences, Inc.

REVB

$0.90 -0.65% $-0.00

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$134.52 1.86% $2.45

Uptrend

Vanguard Extended Market Index Fund

VXF

$178.36 0.55% $0.97

Uptrend

Downtrend

Similar stocks (19)

Apellis Pharmaceuticals, Inc.

APLS

$36.31 -3.48% $-1.31

Downtrend

Structure Therapeutics Inc.

GPCR

$40.00 -2.06% $-0.84

Downtrend

Arcus Biosciences, Inc.

RCUS

$16.91 -5.79% $-1.04

Neutral

Relay Therapeutics, Inc.

RLAY

$8.11 6.71% $0.51

Downtrend

Day One Biopharmaceuticals, Inc.

DAWN

$13.63 -3.54% $-0.50

Downtrend

Cullinan Oncology, Inc.

CGEM

$16.93 -5.68% $-1.02

Uptrend

Annexon, Inc.

ANNX

$7.16 -0.62% $-0.04

Uptrend

iTeos Therapeutics, Inc.

ITOS

$12.10 -27.54% $-4.60

Uptrend

Inozyme Pharma, Inc.

INZY

$5.99 -0.17% $-0.01

Uptrend

TScan Therapeutics, Inc.

TCRX

$5.74 0.00% $0.00

Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.54 -2.31% $-0.06

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.66 -6.69% $-0.05

Downtrend

Immix Biopharma, Inc.

IMMX

$1.85 -1.07% $-0.02

Downtrend

Unicycive Therapeutics, Inc.

UNCY

$0.38 -5.01% $-0.02

Downtrend

Palisade Bio, Inc.

PALI

$3.89 2.64% $0.10

Downtrend

TransCode Therapeutics, Inc.

RNAZ

$0.26 0.50% $0.00

Downtrend

Phio Pharmaceuticals Corp.

PHIO

$3.31 0.30% $0.01

Downtrend

ZyVersa Therapeutics, Inc.

ZVSA

$2.38 9.17% $0.20

Downtrend

Revelation Biosciences, Inc.

REVB

$0.90 -0.65% $-0.00

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$134.52 1.86% $2.45

Uptrend

Vanguard Extended Market Index Fund

VXF

$178.36 0.55% $0.97

Uptrend